Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.25
-0.05 (-0.68%)
May 9, 2025, 12:19 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Biopharma
6.14B
Log In
Log In
Log In
Log In
Upgrade
Biopharma Growth
10.51%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic
644.90M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Growth
-3.79%
Log In
Log In
Log In
Log In
Upgrade
Bio Supplies
215.66M
Log In
Log In
Log In
Log In
Upgrade
Bio Supplies Growth
34.83%
Log In
Log In
Log In
Log In
Upgrade
Other
209.23M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
2.84%
Log In
Log In
Log In
Log In
Upgrade
Intersegments
-
Log In
Log In
Log In
Log In
Upgrade
Intersegments Growth
-
Log In
Log In
Log In
Log In
Upgrade
Hospital
-
Log In
Log In
Log In
Log In
Upgrade
Hospital Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States and Canada
4.09B
Log In
Log In
Log In
Log In
Upgrade
United States and Canada Growth
4.82%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
1.58B
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
10.22%
Log In
Log In
Log In
Log In
Upgrade
Rest of European Union
1.12B
Log In
Log In
Log In
Log In
Upgrade
Rest of European Union Growth
25.22%
Log In
Log In
Log In
Log In
Upgrade
Spain
423.08M
Log In
Log In
Log In
Log In
Upgrade
Spain Growth
16.59%
Log In
Log In
Log In
Log In
Upgrade